Dr. Seodhna M. Lynch received her BS degree in Biomedical Sciences from Queen’s University Belfast (2010), MS degree in Biomedical Sciences with Specialist Study in Haematology and Transfusion Sciences from Ulster University (2011), and PhD degree in Genomic Medicine Research Group from Ulster University (2016). She is now the Post-Doctoral Research Associate within the School of Medicine at Ulster University and Memorial Sloan Kettering Cancer Center (MSKCC). Her research interests mainly aim to identifying novel biomarkers in cancer for directing personalised cancer therapy and specifically developing novel therapeutics for paediatric acute myeloid leukaemia.
Victoria E. McGilligan received her PhD in Immunology (2006) from Ulster University. She is now the Senior Lecturer in Personalised Medicine within the School of Medicine at Ulster University. Her research interests are in immunological and inflammatory disease with a key interest in the NLRP3 Inflammasome, therapeutic antibody development and biomarker translation.
Dr. Steven Watterson is Computational Biologist at the Personalised Medicine Centre, Ulster University. He completed his PhD studies in Mathematics at Trinity College, Dublin and has worked and studied at Edinburgh University and Los Alamos National Laboratories. He has published 51 papers in various journals, and serves as a the editorial board of Frontiers in Synthetic Biology and the Journal of Personalised Medicine. He current serves as lecturer on the BSc Personalised Medicine, MSc Personalised Medicine and MSc Biotechnology programmes. His interests include cholesterol metabolism, cardiovascular disease, machine learning and systems modelling approaches.
Dr Priyank Shukla earned a BSc in Biotechnology (2004) from Bareilly College, MJPR University, and MSc in Bioinformatics (2006) from University Institute of Engineering & Technology, CSJM University, and a PhD in Computer Science (2010) from University of Bologna. He is now a Senior Lecturer in Stratified Medicine (Bioinformatics) at Ulster University. His current research interests are in the fields of Personalised Medicine and Bioinformatics.
Maurice O'Kane is consultant chemical pathologist in Altnagelvin Hospital, Londonderry, director of research Western Health and Social Care Trust, and chief executive officer of the Clinical Translational research and Innovation Centre. He completed his PhD studies in Medicine at the University of Edinburgh. His interests include diabetes and point of care testing.
Dr. David S. Gibson is a Senior Lecturer at the School of
Biomedical Sciences, Ulster University. After his Biochemistry degree, he
worked at Randox Laboratories Ltd and was responsible for designing and
commercializing novel biochip array diagnostic tests. He was awarded a PhD in
2001 from the Centre for Cancer Research and Cell Biology, Queen’s University
Belfast (QUB). In 2009, he was awarded a prestigious travel fellowship from
Arthritis Research UK to conduct mass spectrometry-based research at the Duncan
laboratory at the University of Colorado, Denver over two years. He is
particularly interested in developing new prognostic and predictive tools to
improve the clinical management of arthritis patients.
Dr. Taranjit Singh Rai is a Senior Lecturer at the School of Medicine, Ulster University. He received a PhD from PGIMER, Chandigarh, India and Post Doctoral training at the Beatson Institute of Cancer Research, Glasgow, and has been awarded for outstanding research and teaching such as young scientist, CATE UK HE and UWS STARS Award. He has published more than 30 collaborative papers in high impact peer-reviewed journals (h-index of 23 and >3000 citations). His teaching disciplines include Cell/Molecular biology, Epigenetics, Ageing, Chromatin, Bio-entrepreneurship, and he is interested in the role of cellular senescence in health and disease.
